David Francisco

Insider Reports History

Location
Canton, MA
Signature
/s/ William R. Kolb, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Francisco:

Company Role Class Num Shares Value Price $ Report Date Ownership
Organogenesis Holdings Inc. Chief Financial Officer Class A Common Stock 731,020 $2,807,116 $3.84 18 Feb 2026 Direct
Organogenesis Holdings Inc. Chief Financial Officer Stock Option (Right to Buy) 111,358 18 Feb 2026 Direct

Insider Reports Filed by David Francisco

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORGO Organogenesis Holdings Inc. 18 Feb 2026 4 -$55,837 4 Chief Financial Officer 20 Feb 2026, 17:28
ORGO Organogenesis Holdings Inc. 15 Feb 2026 4 -$195,631 4 Chief Financial Officer 18 Feb 2026, 16:37
ORGO Organogenesis Holdings Inc. 19 Feb 2025 2 $0 4 Chief Financial Officer 21 Feb 2025, 17:49
ORGO Organogenesis Holdings Inc. 15 Feb 2025 4 -$129,711 4 Chief Financial Officer 19 Feb 2025, 19:17
ORGO Organogenesis Holdings Inc. 21 Feb 2024 2 $0 4 Chief Financial Officer 23 Feb 2024, 17:24
ORGO Organogenesis Holdings Inc. 15 Feb 2024 3 -$85,521 4 Chief Financial Officer 20 Feb 2024, 20:18
ORGO Organogenesis Holdings Inc. 22 Feb 2023 2 $0 4 Chief Financial Officer 24 Feb 2023, 16:49
ORGO Organogenesis Holdings Inc. 15 Feb 2023 2 -$12,858 4 Chief Financial Officer 17 Feb 2023, 15:24
ORGO Organogenesis Holdings Inc. 15 Feb 2022 4 -$22,479 4 Chief Financial Officer 17 Feb 2022, 17:51